Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Browse
News
Browse

Showing: All

ASH 2019: New drug markedly improves overall survival in patients with AML in remission

(10 Dec 2019)

ASH 2019: Study reveals genetic underpinnings of AML and myelodysplastic syndrome

(10 Dec 2019)

ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myeloma

(10 Dec 2019)

ASH 2019: Immunotherapy superior to chemotherapy for children with relapsed B-ALL

(10 Dec 2019)

ASH 2019: Daratumumab shows overall survival benefit and continued improvement in progression-free survival in patients with newly diagnosed multiple myeloma who are ineligible for transplant

(09 Dec 2019)

Anti-CTLA-4 antibody tremelimumab shows efficacy in patients with metastatic bladder cancer

(09 Dec 2019)

ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition

(09 Dec 2019)

ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results

(09 Dec 2019)

ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma

(09 Dec 2019)

ASH 2019: CAR-T immunotherapy shows success and reduces health care utilisation in older patients

(09 Dec 2019)

Last Next


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation